Chiltern International Limited (Chiltern)

It’s a global Clinical Research Organization (CRO) providing clinical development and staffing services in Europe, the Americas and India, today announced the acquisition of Vigiun, a full service Clinical Research Organization located in Sao Paulo, Brazil. Established in 1999 by Eduardo Forleo, MD, and Elisa Halker, BSN, Vigiun has extensive experience conducting clinical trials in a variety of therapeutic areas, in particular infectious disease, oncology, and respiratory. Latin America has a population of 503 million people, of which 192 million are in Brazil. This vast population provides a significant number of potential patients in all disease areas. Latin America is rich with experienced investigators and is known for high quality data and excellent patient retention in clinical trials. About Chiltern:Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries and employs 1400 staff across 28 countries. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Further information is available at www.chiltern.com.